Research graph
References from The road ahead for CLL care in sub-Saharan Africa. Local targets link to admitted publications; unresolved targets remain external evidence.
Bridging the diagnostic gap in CLL through TP53 molecular diagnostics in sub-Saharan Africa
10.1016/j.bglo.2026.100130 · 2026 · External reference
TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
10.3324/haematol.2018.187583 · 2018 · External reference
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
10.1182/blood-2017-09-806398 · 2018 · External reference
EHA guidelines on management of chronic lymphocytic leukemia and Richter transformation
10.1002/hem3.70403 · 2026 · External reference
NCCN Guidelines(R) insights: chronic lymphocytic leukemia/small lymphocytic lymphoma, version 2.2026
10.6004/jnccn.2026.0012 · 2026 · External reference
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update
10.1038/s41375-024-02267-x · 2024 · External reference
Delays in seeking, reaching and access to quality cancer care in sub-Saharan Africa: a systematic review
10.1136/bmjopen-2022-067715 · 2023 · External reference
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia
10.1038/s41598-018-30330-y · 2018 · External reference
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing
10.1186/s13000-016-0550-y · 2016 · External reference
Characteristics of chronic lymphocytic leukemia in Senegal
10.1186/s12878-016-0051-y · 2016 · External reference
EHA guidelines on management of chronic lymphocytic leukemia and Richter transformation
10.1002/hem3.70403 · ExternalCitation · doi-reference
Bridging the diagnostic gap in CLL through TP53 molecular diagnostics in sub-Saharan Africa
10.1016/j.bglo.2026.100130 · ExternalCitation · doi-reference
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update
10.1038/s41375-024-02267-x · ExternalCitation · doi-reference
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia
10.1038/s41598-018-30330-y · ExternalCitation · doi-reference
Delays in seeking, reaching and access to quality cancer care in sub-Saharan Africa: a systematic review
10.1136/bmjopen-2022-067715 · ExternalCitation · doi-reference
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
10.1182/blood-2017-09-806398 · ExternalCitation · doi-reference
Characteristics of chronic lymphocytic leukemia in Senegal
10.1186/s12878-016-0051-y · ExternalCitation · doi-reference
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing
10.1186/s13000-016-0550-y · ExternalCitation · doi-reference
TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
10.3324/haematol.2018.187583 · ExternalCitation · doi-reference
NCCN Guidelines(R) insights: chronic lymphocytic leukemia/small lymphocytic lymphoma, version 2.2026
10.6004/jnccn.2026.0012 · ExternalCitation · doi-reference
